Mellon on the Markets: Lessons learned
6 mins. to read
Inside the mind of the Master Investor: British billionaire Jim Mellon updates on his latest investing and trading activities.
Jim Mellon
Mellon on the Markets: The pivot to Asia
6 mins. to read
Inside the mind of the Master Investor: British billionaire Jim Mellon updates on his latest investing and trading activities.
Mellon on the Markets: Playing the rotation game
5 mins. to read
Inside the mind of the Master Investor: Billionaire Jim Mellon updates on his latest market insights and investing activity.
Jim Mellon: Reality sinks in for the FANGs
6 mins. to read
Inside the mind of the Master Investor: Billionaire Jim Mellon reveals his latest views on the FANG stocks, Brexit, and markets in general.
Jim Mellon predicts “big fall” in markets
6 mins. to read
Inside the mind of the Master Investor: Jim Mellon gets bearish as he sees signs of a market top and predicts “big falls” on the horizon.
Mellon on the Markets
5 mins. to read
At no point in my life has tempus seemed to fugit more than now. This year is nearly half over. I am at my house in the Isle of Man, a glass-fringed old café, and the place is boiling. Is this climate change or just an early summer? Who knows, but all this extraordinary weather will undoubtedly…
Mellon on the Markets
6 mins. to read
It’s late April in LA, it’s raining, and it’s time for the annual Milken Institute jamboree. Anthony Chow and I are here, having been relieved of a large sum in order to attend. As with most conferences, the true value is in the networking effect, not so much in what is said at the various…
Mellon on the Markets
5 mins. to read
Normal service was somewhat delayed by the exigencies of the road trip I have been on for two weeks to Asia and Australia. My colleague Anthony Chow and I have been doing the crossover (i.e. pre-IPO) institutional/UHNW (ultra-high net worth) round for Juvenescence Ltd and the result has been that by the time I get…
Mellon on the Markets
6 mins. to read
The mini collapse in shares earlier in February must surely presage something more serious. In my excessively long experience of markets, the first shudder is rarely the last. Emollient words from inexperienced market commentators should be roundly ignored. This bull market is approaching the shadows of its duration and investors should make use of the…
Mellon on the Markets
6 mins. to read
Another year, another pilgrimage to the JP Morgan Biotech conference in San Francisco, now in its 26th year. About 9,000 people scurry around the passageways of the far-too-small-for-purpose St Francis hotel, watching companies present stuff that is now readily available online. The smarter lot, who number about 41,000, hover in the periphery of the conference,…